Novo Nordisk A/S (NVO)

39.05 +0.55 (+1.43%) USD  |  NYSE  |  Mar 05, 16:00
39.11 +0.06 (+0.15%) After-Hours: 19:31
More

Novo Nordisk EPS Diluted from Tax Loss Carryforward (Quarterly)

EPS Diluted from Tax Loss Carryforward (Quarterly) Chart

View EPS Diluted from Tax Loss Carryforward (Quarterly) for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Tax Loss Carryforward (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

View EPS Diluted from Tax Loss Carryforward (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Tax Loss Carryforward (Quarterly) Benchmarks

View EPS Diluted from Tax Loss Carryforward (Quarterly) Benchmarks
Start Trial
Ascendis Pharma A/S --
Evaxion AS --
Regeneron Pharmaceuticals, Inc. --
Viking Therapeutics, Inc. --
DBV Technologies SA --